The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3,6-Diamino-acridin-9-ylamino)-N-methyl-benzenesulfonamide ID: ALA35072
PubChem CID: 9977885
Max Phase: Preclinical
Molecular Formula: C20H19N5O2S
Molecular Weight: 393.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CNS(=O)(=O)c1ccc(Nc2c3ccc(N)cc3nc3cc(N)ccc23)cc1
Standard InChI: InChI=1S/C20H19N5O2S/c1-23-28(26,27)15-6-4-14(5-7-15)24-20-16-8-2-12(21)10-18(16)25-19-11-13(22)3-9-17(19)20/h2-11,23H,21-22H2,1H3,(H,24,25)
Standard InChI Key: AVPYNABDMYYIMV-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
9.3667 -8.6417 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.5292 -11.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5375 -12.7875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2417 -11.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8167 -11.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2500 -12.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8167 -12.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5250 -10.3042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6542 -9.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9667 -12.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1042 -12.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9542 -11.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1042 -11.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3667 -7.8167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3667 -9.4667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1917 -8.6417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6625 -9.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9375 -8.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2375 -9.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3917 -12.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6792 -12.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3917 -11.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6750 -11.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4042 -12.7667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6750 -12.7917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9500 -10.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2292 -9.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6042 -7.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 8 1 0
3 7 1 0
4 2 2 0
5 2 1 0
6 4 1 0
7 5 1 0
8 19 1 0
9 1 1 0
10 6 1 0
11 7 2 0
12 4 1 0
13 5 2 0
14 1 2 0
15 1 2 0
16 1 1 0
17 9 2 0
18 9 1 0
19 27 1 0
20 22 2 0
21 23 1 0
22 13 1 0
23 12 2 0
24 21 1 0
25 20 1 0
26 17 1 0
27 18 2 0
28 16 1 0
19 26 2 0
3 6 2 0
11 20 1 0
10 21 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.47Molecular Weight (Monoisotopic): 393.1259AlogP: 3.20#Rotatable Bonds: 4Polar Surface Area: 123.13Molecular Species: BASEHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.89CX Basic pKa: 10.19CX LogP: 1.68CX LogD: 0.44Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.31Np Likeness Score: -1.05
References 1. Gamage SA, Tepsiri N, Wilairat P, Wojcik SJ, Figgitt DP, Ralph RK, Denny WA.. (1994) Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum., 37 (10): [PMID:8182707 ] [10.1021/jm00036a014 ]